title: Effect of the carbonic anhydrase inhibitor, acetazolamide, on Helicobacter pylori infection in vivo: a pilot study.
abstract: BACKGROUND
  Carbonic anhydrase inhibitors have been successfully used to treat peptic ulcers. Although carbonic anhydrase restriction does not inhibit Helicobacter pylori in vitro, recent studies suggest that carbonic anhydrase inhibition reduces the ability of H. pylori to survive in an acid environment as present in the stomach.
  
  
  METHODS
  In a pilot study, we examined the effect of acetazolamide 500 mg as twice a day for 4 days in volunteers with active H. pylori infection. Effectiveness was judged by changes in the results of the urea breath test.
  
  
  RESULTS
  Eight H. pylori infected volunteers completed the test. No urea breath test reverted to negative and there was a trend for the urea breath test value to increase [e.g. delta over baseline (DOB) mean +/- SE increased from 50.9 +/- 13 at baseline to 64.9 +/- 13 at day 5] during treatment with acetazolamide.
  
  
  CONCLUSIONS
  The potential effect of carbonic anhydrase inhibitors on acid secretion may prevent effect on H. pylori in vivo and/or the sites of infection at the surface of the stomach may have a pH higher for any postulated acid-dependent effect to have an effect clinically.
authors.affiliation: The Department of Medicine, Baylor College of Medicine, Houston, TX, USA.
authors.forename: Rassa
authors.initials: R
authors.lastname: Shahidzadeh
authors.forename: Antone
authors.initials: A
authors.lastname: Opekun
authors.forename: Akiko
authors.initials: A
authors.lastname: Shiotani
authors.forename: David Y
authors.initials: DY
authors.lastname: Graham
mesh_terms: D000086:Acetazolamide / Q000627:therapeutic use*; D000328:Adult; D001944:Breath Tests; D002257:Carbonic Anhydrase Inhibitors / Q000627:therapeutic use*; D005260:Female; D016481:Helicobacter Infections / Q000188:drug therapy*; D006801:Humans; D008297:Male; D008875:Middle Aged; D010865:Pilot Projects
chemical_list: D002257:Carbonic Anhydrase Inhibitors; D000086:Acetazolamide